Published in Oncogene on October 03, 2002
Cortactin branches out: roles in regulating protrusive actin dynamics. Cell Motil Cytoskeleton (2008) 2.26
The helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis. Proc Natl Acad Sci U S A (2009) 1.34
Src phosphorylation of Alix/AIP1 modulates its interaction with binding partners and antagonizes its activities. J Biol Chem (2004) 1.02
The Phe105 loop of Alix Bro1 domain plays a key role in HIV-1 release. Structure (2011) 1.01
Migfilin interacts with Src and contributes to cell-matrix adhesion-mediated survival signaling. J Biol Chem (2009) 0.95
Extracellular Alix regulates integrin-mediated cell adhesions and extracellular matrix assembly. EMBO J (2008) 0.86
Amplification patterns of three genomic regions predict distant recurrence in breast carcinoma. J Mol Diagn (2007) 0.82
Proteomic analysis of proton beam irradiated human melanoma cells. PLoS One (2014) 0.82
Association between Programmed Cell Death 6 Interacting Protein Insertion/Deletion Polymorphism and the Risk of Breast Cancer in a Sample of Iranian Population. Dis Markers (2015) 0.77
Alternative polyadenylation produces two major transcripts of Alix. Arch Biochem Biophys (2007) 0.75
βTrCP controls the lysosome-mediated degradation of CDK1, whose accumulation correlates with tumor malignancy. Oncotarget (2014) 0.75
Variations in the PDCD6 gene are associated with increased uterine leiomyoma risk in the Chinese. Genet Test Mol Biomarkers (2013) 0.75
Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer (2005) 2.86
Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation. Mol Biol Cell (2002) 2.56
SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res (2005) 2.07
Insulin acutely decreases hepatic fatty acid synthase activity. Cell Metab (2005) 1.99
Regulation of Cdc25C by ERK-MAP kinases during the G2/M transition. Cell (2007) 1.97
Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features. Cancer (2002) 1.95
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. J Clin Invest (2008) 1.87
Stem-cell origin of metastasis and heterogeneity in solid tumours. Lancet Oncol (2002) 1.74
Roles of Greatwall kinase in the regulation of cdc25 phosphatase. Mol Biol Cell (2008) 1.68
Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Mol Cancer Res (2008) 1.67
Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells. Exp Cell Res (2004) 1.59
Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts. Cancer Res (2010) 1.46
Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene (2005) 1.43
CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis. Clin Cancer Res (2010) 1.42
Poor sleep quality, stress status, and sympathetic nervous system activation in nondipping hypertension. Blood Press Monit (2011) 1.40
Stanniocalcin 1 and ovarian tumorigenesis. J Natl Cancer Inst (2010) 1.33
SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity (2006) 1.33
Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis. Breast Cancer Res (2008) 1.30
NudC is required for Plk1 targeting to the kinetochore and chromosome congression. Curr Biol (2006) 1.30
Involvement of the conserved adaptor protein Alix in actin cytoskeleton assembly. J Biol Chem (2006) 1.30
SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms. J Biol Chem (2010) 1.29
β-N-Acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3. J Biol Chem (2012) 1.25
BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res (2011) 1.23
Understanding the biology of bone metastases: key to the effective treatment of prostate cancer. Clin Cancer Res (2008) 1.22
Role for NudC, a dynein-associated nuclear movement protein, in mitosis and cytokinesis. J Cell Sci (2003) 1.21
Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancer. Cancer Discov (2013) 1.18
The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog. Gynecol Oncol (2011) 1.13
A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells. Cancer Res (2007) 1.07
Nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) modulates mesenchymal cell commitment and differentiation. Proc Natl Acad Sci U S A (2011) 1.06
Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. Cancer Res (2004) 1.06
Androgen depletion up-regulates cadherin-11 expression in prostate cancer. J Pathol (2010) 1.04
Biology and clinical management of prostate cancer bone metastasis. Front Biosci (2007) 1.04
Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow. J Pathol (2004) 1.03
Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy. J Clin Oncol (2005) 1.03
CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation. J Clin Invest (2004) 1.02
Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis. Mol Cancer Res (2013) 1.01
Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cells. Mol Cancer Res (2007) 1.00
16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway. Cancer Res (2007) 1.00
The central role of osteoblasts in the metastasis of prostate cancer. Cancer Metastasis Rev (2006) 0.99
Decoding the intrinsic mechanism that prohibits ALIX interaction with ESCRT and viral proteins. Biochem J (2010) 0.98
Prostate cancer stem cells. Clin Genitourin Cancer (2012) 0.96
Expression of the extracellular domain of OB-cadherin as an Fc fusion protein using bicistronic retroviral expression vector. Protein Expr Purif (2008) 0.96
Loss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer. PLoS One (2013) 0.95
The effect of zolpidem on sleep quality, stress status, and nondipping hypertension. Sleep Med (2011) 0.94
Inhibition of FOXO3 tumor suppressor function by betaTrCP1 through ubiquitin-mediated degradation in a tumor mouse model. PLoS One (2010) 0.93
Acetylation of RNA processing proteins and cell cycle proteins in mitosis. J Proteome Res (2010) 0.93
The HIV-1 p6/EIAV p9 docking site in Alix is autoinhibited as revealed by a conformation-sensitive anti-Alix monoclonal antibody. Biochem J (2008) 0.92
The CHMP4b- and Src-docking sites in the Bro1 domain are autoinhibited in the native state of Alix. Biochem J (2009) 0.92
Biological significance of c-met over expression in papillary renal cell carcinoma. J Urol (2002) 0.92
Current trials using bone-targeting agents in prostate cancer. Cancer J (2008) 0.91
Lithium chloride attenuates BMP-2 signaling and inhibits osteogenic differentiation through a novel WNT/GSK3- independent mechanism. Bone (2010) 0.90
16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Endocrinology (2004) 0.90
Expression of recombinant MDA-BF-1 with a kinase recognition site and a 7-histidine tag for receptor binding and purification. Protein Expr Purif (2005) 0.89
Aurora B is regulated by acetylation/deacetylation during mitosis in prostate cancer cells. FASEB J (2012) 0.89
Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation. J Clin Invest (2008) 0.89
Inhibition of prostate tumor angiogenesis by the tumor suppressor CEACAM1. J Biol Chem (2002) 0.88
Effects of insulin-like growth factor-1 on the properties of mesenchymal stem cells in vitro. J Zhejiang Univ Sci B (2012) 0.87
Efficacy of Atorvastatin combined with adipose-derived mesenchymal stem cell transplantation on cardiac function in rats with acute myocardial infarction. Acta Biochim Biophys Sin (Shanghai) (2011) 0.87
Modulation of prostate cancer cell gene expression by cell-to-cell contact with bone marrow stromal cells or osteoblasts. Clin Exp Metastasis (2009) 0.87
Cellular and molecular evidence for malignancy-inhibitory functions of p15RS. Cell Cycle (2012) 0.87
Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer. Future Med Chem (2012) 0.87
16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway. Cancer Res (2005) 0.86
Extracellular Alix regulates integrin-mediated cell adhesions and extracellular matrix assembly. EMBO J (2008) 0.86
Clinical aspects of bone metastases in prostate cancer. Cancer Treat Res (2004) 0.86
Antitumor activity of the 16-kDa prolactin fragment in prostate cancer. Cancer Res (2003) 0.84
Phosphorylation of the proline-rich domain of Xp95 modulates Xp95 interaction with partner proteins. Biochem J (2007) 0.84
One-step isolation of plasma membrane proteins using magnetic beads with immobilized concanavalin A. Protein Expr Purif (2008) 0.83
Expression and purification of the angiogenesis inhibitor 16-kDa prolactin fragment from insect cells. Protein Expr Purif (2003) 0.83
Ectopic expression of FGF-3 results in abnormal prostate and Wolffian duct development. Oncogene (2002) 0.83
MicroRNA-350 induces pathological heart hypertrophy by repressing both p38 and JNK pathways. Biochim Biophys Acta (2012) 0.83
Direct roles of the signaling kinase RSK2 in Cdc25C activation during Xenopus oocyte maturation. Proc Natl Acad Sci U S A (2010) 0.83
Osteolytic and osteoblastic bone metastases: two extremes of the same spectrum? Recent Results Cancer Res (2012) 0.82
Dissecting the M phase-specific phosphorylation of serine-proline or threonine-proline motifs. Mol Biol Cell (2010) 0.82
Metabolic activation of CaMKII by coenzyme A. Mol Cell (2013) 0.82
Multimodality therapy: bone-targeted radioisotope therapy of prostate cancer. Clin Adv Hematol Oncol (2010) 0.82
Aberrant expression of katanin p60 in prostate cancer bone metastasis. Prostate (2011) 0.81
Inhibition of prostate tumor growth by overexpression of NudC, a microtubule motor-associated protein. Oncogene (2004) 0.80
Gene selection for oligonucleotide array: an approach using PM probe level data. Bioinformatics (2004) 0.80
Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinoma. Cancer (2006) 0.80
Metabolic regulation of CaMKII protein and caspases in Xenopus laevis egg extracts. J Biol Chem (2013) 0.80
NudC deacetylation regulates mitotic progression. PLoS One (2013) 0.79
Plasma membrane isolation using immobilized concanavalin A magnetic beads. Methods Mol Biol (2012) 0.77
Tumorhead distribution to cytoplasmic membrane of neural plate cells is positively regulated by Xenopus p21-activated kinase 1 (X-PAK1). Dev Biol (2007) 0.76
Construction of tissue-engineered corpus cavernosum with muscle-derived stem cells and transplantation in vivo. BJU Int (2010) 0.76
[Effect of atorvastatin on cardiac function and TGF-β1 signaling pathway after acute myocardial infarction in rats]. Nan Fang Yi Ke Da Xue Xue Bao (2012) 0.76
Radium-223: Optimizing Treatment and Research of Osteoblastic Bone Metastasis. Oncology (Williston Park) (2015) 0.75